SCHEMBL6424426

SCHEMBL6424426

Cc1c(C(C(=O)O)C2CCC2)c2c(F)c(O)ccc2n1C(=O)c1ccc(F)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HSD11B1 P28845 2/20 0.35
DPP4 P27487 1/20 0.34
KCNH2 Q12809 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
MGLL Q99685 2/20 0.33
FAAH O00519 1/20 0.33
PGR P06401 1/20 0.33
PDE2A O00408 1/20 0.33
GRM5 P41594 2/20 0.32
ALDH1A1 P00352 2/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GPBAR1 Q8TDU6 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
TAS1R2 Q8TE23 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424476 0.98 KMT2A (0.36) KMT2AMEN1HSD11B1DPP4KCNH2
SCHEMBL6426945 0.92 PDE2A (0.35) HSD11B1KCNH2MGLLFAAHPDE2A
SCHEMBL6423582 0.90 PDE2A (0.35) HSD11B1KCNH2MGLLFAAHPDE2A
SCHEMBL6425922 0.90 AKR1C3 (0.40) KMT2AMEN1MGLLAKR1C3AKR1C2
SCHEMBL6426891 0.89 HSD11B1 (0.37) HSD11B1PGRALDH1A1AKR1C3AKR1C2
SCHEMBL6427479 0.89 MEN1 (0.36) KMT2AMEN1HSD11B1DPP4KCNH2
SCHEMBL6424245 0.88 ALDH1A1 (0.37) KMT2AMEN1HSD11B1MGLLGRM5
SCHEMBL6423571 0.88 USP2 (0.39) KMT2AMEN1HSD11B1GRM5ALDH1A1
SCHEMBL6422936 0.88 AKR1C3 (0.40) KMT2AMEN1MGLLALDH1A1AKR1C3
SCHEMBL6427330 0.87 HSD11B1 (0.37) HSD11B1PGRALDH1A1AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 KMT2A 1519/4885MEN1 3824/4885HSD11B1 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.